Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- FLNC -37.3%, HLIT -25.8% (also announces $200 mln buyback plan), PETS -15%, AMKR -9.6%, CMCO -8.5% (also to acquire Kito Crosby Limited from KKR for $2.7 bln), ACLS -8.3%, SQNS -7.3%, MITK -6.5%, MEDP -6.1%, CXW -5.2%, ALAB -4.5%, WCC -3.7%, INSP -3.3% (also receives civil investigate demand), ARWR -3%, CG -2.9%, LZ -2.7% (also acquires Formation Nation), COTY -1.5%, VRTX -1% (also, COO to retire)
Other news:
- THRD -25.8% (announces results from its Phase 1 single and multiple ascending dose clinical trial of THB335 in healthy volunteers)
- SERA -10.1% (stock offering)
- HLNE -3.8% (prices offering of by co and selling stockholder of 1,572,536 shares of Class A common stock for gross proceeds of ~$252 mln)
- LTM -3.4% (Jan Traffic)
- VYGR -3.2% (Provides Update on SOD1 ALS Gene Therapy Program)
- MRP -3% (Completes Acquisition of Rausch Coleman Homes Land Assets)
- HESM -2.8% (upsizes and prices offering of 11.0 mln shares of common stock at $39.45 per share)
- WBA -2.2% (discloses commercial arbitration award update - federal court in Delaware upheld the Arbitration Award)
- ALRM -1.3% (announces a majority-stake acquisition of CHeKT0
Analyst comments:
- DVAX -5.2% (downgraded to Sell from Neutral at Goldman)
- SNAP -1.8% (downgraded to Neutral from Buy at Guggenheim)
- NET -1.7% (downgraded to Sell from Hold at DZ Bank)